Anti-TNF agent etanercept augments UV-induced skin cancer development in SKH-1 mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-TNF agent etanercept augments UV-induced skin cancer development in SKH-1 mice
Authors
Keywords
-
Journal
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2019-12-23
DOI
10.1080/09546634.2019.1708851
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of the Immune System in Cutaneous Squamous Cell Carcinoma
- (2019) Matthew J. Bottomley et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
- (2019) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Malignancy and the Risks of Biologic Therapies
- (2017) Raphaèle Seror et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- The dark side of the light: mechanisms of photocarcinogenesis
- (2016) Margarida Moura Valejo Coelho et al. CLINICS IN DERMATOLOGY
- Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version
- (2015) R.N. Werner et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors
- (2014) P.P.M. van Lümig et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Recovery of the response to biological treatments using narrow band ultraviolet-B in patients with moderate to severe psoriasis: a retrospective study of 17 patients
- (2014) Isabel Belinchón et al. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE
- Cancer risk in immune-mediated inflammatory diseases (IMID)
- (2013) Rudi Beyaert et al. Molecular Cancer
- Infliximab and Etanercept Are Equally Effective in Reducing Enterocyte APOPTOSIS in Experimental Colitis
- (2012) Walter Fries et al. International Journal of Medical Sciences
- Urticaria Pigmentosa After Treatment With TNF Antagonists: A Case Report
- (2011) Pauline Leloup ARCHIVES OF DERMATOLOGY
- Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks
- (2011) T. Gambichler et al. BRITISH JOURNAL OF DERMATOLOGY
- Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial
- (2011) P. Wolf et al. BRITISH JOURNAL OF DERMATOLOGY
- Focus on skin cancer association and progression under TNF antagonist therapy
- (2011) Claudine Piérard-Franchimont et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- 311 nm ultraviolet B-accelerated response of psoriatic lesions in adalimumab-treated patients
- (2011) Peter Wolf et al. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE
- Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence
- (2010) PA Foley et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies
- (2009) Luigi Naldi CLINICS IN DERMATOLOGY
- Low Levels of Tumor Necrosis Factor Increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor Site
- (2008) B. Li et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now